DE69529229D1 - Verfahren und testsätze mit makrophagen stimulierenden proteinen - Google Patents

Verfahren und testsätze mit makrophagen stimulierenden proteinen

Info

Publication number
DE69529229D1
DE69529229D1 DE69529229T DE69529229T DE69529229D1 DE 69529229 D1 DE69529229 D1 DE 69529229D1 DE 69529229 T DE69529229 T DE 69529229T DE 69529229 T DE69529229 T DE 69529229T DE 69529229 D1 DE69529229 D1 DE 69529229D1
Authority
DE
Germany
Prior art keywords
msp
macrophage
test sets
methods
stimulating proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69529229T
Other languages
English (en)
Other versions
DE69529229T2 (de
Inventor
Hava Karsenty Avraham
Paul J Godowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Beth Israel Deaconess Medical Center Inc
Original Assignee
Genentech Inc
Beth Israel Deaconess Medical Center Inc
Beth Israel Hospital Association
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc, Beth Israel Deaconess Medical Center Inc, Beth Israel Hospital Association filed Critical Genentech Inc
Application granted granted Critical
Publication of DE69529229D1 publication Critical patent/DE69529229D1/de
Publication of DE69529229T2 publication Critical patent/DE69529229T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69529229T 1994-11-03 1995-10-25 Verfahren und testsätze mit makrophagen stimulierenden proteinen Expired - Lifetime DE69529229T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/334,177 US5696086A (en) 1994-11-03 1994-11-03 Methods and kits using macrophage stimulating protein
PCT/US1995/013830 WO1996014082A1 (en) 1994-11-03 1995-10-25 Methods and kits using macrophage stimulating protein

Publications (2)

Publication Number Publication Date
DE69529229D1 true DE69529229D1 (de) 2003-01-30
DE69529229T2 DE69529229T2 (de) 2003-09-11

Family

ID=23305958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69529229T Expired - Lifetime DE69529229T2 (de) 1994-11-03 1995-10-25 Verfahren und testsätze mit makrophagen stimulierenden proteinen

Country Status (8)

Country Link
US (1) US5696086A (de)
EP (1) EP0789583B1 (de)
JP (1) JP3769691B2 (de)
AT (1) ATE229813T1 (de)
CA (1) CA2203528C (de)
DE (1) DE69529229T2 (de)
DK (1) DK0789583T3 (de)
WO (1) WO1996014082A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948892A (en) 1996-12-16 1999-09-07 Amgen Inc. Analogs of macrophage stimulating protein
IT1292017B1 (it) * 1997-05-28 1999-01-25 Dompe Spa Composizioni farmaceutiche contenenti la proteina stimolante i macrofagi per il trattamento di patologie del sistema nervoso
US6979442B1 (en) 1998-08-17 2005-12-27 Pfizer Inc. Stabilized protein compositions
AU2002258798A1 (en) * 2001-04-13 2002-10-28 Children's Hospital Medical Center Methods for the treatment of hepatic disorders
WO2014085676A1 (en) * 2012-11-30 2014-06-05 Genentech, Inc. Ron compositions and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
IL92937A0 (en) * 1989-01-31 1990-09-17 Us Health Human derived monocyte attracting protein,pharmaceutical compositions comprising it and dna encoding it
US5362716A (en) * 1989-12-27 1994-11-08 The United States Of America As Represented By The Department Of Health And Human Services Methods for stimulating hematopoietic progenitors using hepatocyte growth factor and lymphokines
US5219991A (en) * 1990-09-21 1993-06-15 The United States Of America As Represented By The Department Of Health And Human Services Macrophage stimulating protein
US5227158A (en) * 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
US5328837A (en) * 1992-05-18 1994-07-12 Genentech, Inc. Hepatocyte growth factor protease domain variants
US5316921A (en) * 1992-05-18 1994-05-31 Genentech, Inc. Single-chain hepatocyte growth factor variants
US5352680A (en) * 1992-07-15 1994-10-04 Regents Of The University Of Minnesota Delta opioid receptor antagonists to block opioid agonist tolerance and dependence
IL107366A (en) * 1992-10-23 2003-03-12 Chugai Pharmaceutical Co Ltd Genes coding for megakaryocyte potentiator
JP3682984B2 (ja) * 1993-10-06 2005-08-17 テルモ株式会社 巨核球増加剤および血小板増加剤
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein

Also Published As

Publication number Publication date
DK0789583T3 (da) 2003-04-07
DE69529229T2 (de) 2003-09-11
MX9703134A (es) 1998-10-31
WO1996014082A1 (en) 1996-05-17
EP0789583B1 (de) 2002-12-18
CA2203528C (en) 2010-04-13
EP0789583A1 (de) 1997-08-20
JP3769691B2 (ja) 2006-04-26
JPH10509446A (ja) 1998-09-14
ATE229813T1 (de) 2003-01-15
US5696086A (en) 1997-12-09
CA2203528A1 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
HUT76970A (hu) Készítmény az érrendszer specifikus koagulálásához
ATE82495T1 (de) Verfahren zur herstellung pharmazeutischer mischungen.
ATE396735T1 (de) Hybride immunglobuline zur verwendung in therapeutischen verfahren
ATE185602T1 (de) Verändertes menschliches il-6
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
IL95429A0 (en) Living tissue equivalents and their production
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
DE3865690D1 (de) Artikulator zur anpassung von kiefermodellen und entsprechendes verfahren.
ATE178616T1 (de) Verfahren zur herstellung von biologisch aktivem protein (z.b. tgf)
DE69014216D1 (de) Verfahren und Apparat zur Herstellung von Faserprodukten in fortlaufender Länge.
DE69534468D1 (de) Wachstums-differenzierungsfaktor-11
FI103506B1 (fi) Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote
EP0804221A4 (de) Methoden und kits zur stimulierung der produktion von megakaryocyten und thrombocyten
GR3006073T3 (de)
DE69529229D1 (de) Verfahren und testsätze mit makrophagen stimulierenden proteinen
ATE179992T1 (de) Zusammensetzungen und methoden zur stimulation der produktion von blutplättchen mittels nicht gebundenem mpl-rezeptor
ATE407217T1 (de) Hochexpression und herstellung von recombinanter s-adenosyl homocysteinase mit hochspezifischer aktivität und verbesserte testverfahren für s- adenosylmethionine (sam)
DE68919282D1 (de) Verfahren zur Herstellung von Cephalosporin und Zwischenverbindungen.
DE3853079D1 (de) Liposome hoher stabilität und verfahren zur herstellung und verwendung.
ATE94905T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten.
MX9803272A (es) N-oxido de lubelozol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition